Dibenzazepine Agents in Epilepsy: How Does Eslicarbazepine Acetate Differ?

por Lawthom, Charlotte, Peltola, Jukka, McMurray, Rob, Dodd, Emma, Villanueva, Vicente
Publicado 2018

Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study

por Lawthom, Charlotte, Bermejo, Pedro, Campos, Dulce, McMurray, Rob, Villanueva, Vicente
Publicado 2019

Exploring seizure management in hospitals, unmet need, and the impact of the COVID-19 pandemic on seizure presentations to hospital

por Ellis, Bethan, Chilcott, Ellie, John, Keri, Parry, Julie, Capeling, Louise, Lawthom, Charlotte, Harding, Katharine, Anderson, Joseph
Publicado 2022

Protocol for a realist and social return on investment evaluation of the use of patient-reported outcomes in four value-based healthcare programmes

por Roberts, Gareth, Cahill, Adele, Lawthom, Charlotte, Price, Martine, Blyth, Christopher, Jones, Carys, Mc Laughlin, Leah, Noyes, Jane
Publicado 2023

Forecasting stroke-like episodes and outcomes in mitochondrial disease

por Ng, Yi Shiau, Lax, Nichola Z, Blain, Alasdair P, Erskine, Daniel, Baker, Mark R, Polvikoski, Tuomo, Thomas, Rhys H, Morris, Christopher M, Lai, Ming, Whittaker, Roger G, Gebbels, Alasdair, Winder, Amy, Hall, Julie, Feeney, Catherine, Farrugia, Maria Elena, Hirst, Claire, Roberts, Mark, Lawthom, Charlotte, Chrysostomou, Alexia, Murphy, Kevin, Baird, Tracey, Maddison, Paul, Duncan, Callum, Poulton, Joanna, Nesbitt, Victoria, Hanna, Michael G, Pitceathly, Robert D S, Taylor, Robert W, Blakely, Emma L, Schaefer, Andrew M, Turnbull, Doug M, McFarland, Robert, Gorman, Gráinne S
Publicado 2021